The case for universal measurement of clinical performance now seems unanswerable 1 . However, as a recent OECD conference has highlighted, the obstacles to implementing an efficient and effective system of performance measurement are formidable 2 . To get the most out of performance measurement, certain design issues need to be addressed. In this paper we consider two aspects of design: what should a clinical performance measurement system seek to measure? And how should we measure it? In the second and concluding part, we shall look at the pitfalls and how to avoid them.
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WHAT SHOULD BE MEASURED?
The rhetoric of clinical performance management is that the focus should always be on the outcomes rather than the processes of healthcare 3 . Certainly, outcomes represent the ultimate product of healthcare: they embody the additional quality and quantity of life added by clinical intervention. In practice, finding an operational way of capturing outcomes is a daunting task. In the past, mortality rates have often served as a proxy for outcome. Their manifest shortcomings have led to the development of broader generic quality-oflife measurement instruments such as EQ-5D and SF36 4, 5 , and a plethora of condition-specific measures.
However, if the focus is on identifying and remedying apparent variations in performance, it is often preferable to measure not only outcomes but also the desirable processes of care. These can be viewed as professional actions recommended as good practice on the basis of expert opinion or evidence. From a performance management perspective, the key issue is that a desirable process should be unambiguously associated with improved patient health outcomes 6 . Monitoring the process can then be a substitute for measuring outcome. What are the advantages and disadvantages of process and outcome measures?
ADVANTAGES OF OUTCOME MEASURES
A focus on outcomes helps direct clinical attention towards a single goal-the patient's health status-rather than specific interventions. It can promote 'whole system' collaboration between different parts of the healthcare system. It may nurture innovation, since clinicians are encouraged to pursue technologies that will enhance outcome, whereas a focus on processes can encourage a 'ritual' approach that inhibits the search for new modes of care.
Outcomes are often long-term in nature. Managerial attention to outcomes encourages providers to adopt technologies (such as health promotion) that recognize long-term benefits, rather than myopic 'patch-up' technologies that ultimately yield worse results.
Some measures of outcome are generic, and once implemented are likely to require only refinement rather than wholesale review. Almost all measures of process are specific to the technology used, and may become obsolete. Some aspects of outcome measures-most notably mortality-are relatively immune to manipulation by providers (although clinicians may be able to influence risk-adjusted outcome measures by exaggerating the risk characteristics of their patients) 7 . In contrast, many measures of process must rely on self-reported activity on the part of clinicians, and are therefore vulnerable to misrepresentation.
ADVANTAGES OF PROCESS MEASURES
The most obvious reason for measuring the processes of care is that certain aspects of process (such as speed of access and the patient experience) are valued in themselves by patients, whatever the clinical outcome. These are particularly important in the management of chronic disease. For example, in end-stage renal failure there are elements of the processes of care, independent of the clinical outcome secured, that make an important contribution to quality of life. More generally, long waits to receive care are clearly a source of anxiety, pain and economic hardship. The results of the public consultation undertaken for the NHS Plan confirmed the importance of process issues 8 , and the World Health Organization made responsiveness a central component of its national performance ratings 9 .
In some services there may be no consensus regarding what constitutes desired outcome (for example, in much of primary care). Even when there is general agreement regarding the appropriate concept of outcome (for example, mortality after surgery), agreeing a measure of the concept may be difficult. How long after surgery should outcome be measured? Should the quality of survival be measured? Even if these issues can be resolved, collecting the agreed outcome measure may be complex and costly.
Many outcomes of care become evident only after much time has elapsed. In long-term follow-up of patients the number of 'missing' observations may be very high, particularly amongst patients with adverse outcomes. Furthermore, reporting of adverse outcomes may be the responsibility of the very clinicians whose performance is being assessed, creating an incentive for under-reporting. Even if accurate measures of outcome can be assembled, their dissemination may be too late to influence clinical behaviour 6 .
Measures of process are usually readily attributable to the provider of care, and so are easily interpreted. By contrast, outcome measures are commonly open to challenge 10 : for example, they tend to be influenced by factors other than healthcare intervention (such as patient compliance and social circumstances), and so may require adjustment before any judgments can be made about professional performance. Outcome measures such as surgical mortality rates are often insensitive to the quality of healthcare received, or display a lot of random noise 11 . They are therefore often difficult to interpret with low volumes of patients (say at individual surgeon level or even unit level).
The philosophy underlying the production of clinical guidelines and pathways of care is that there exist readily monitored processes that lead to desired outcomes. Use of process performance measures is consistent with this philosophy. With appropriate use of information technology, many process measures such as patterns of drug prescribing can be made available rapidly, and unusual performance can be identified and acted on quickly if necessary. Poor performance on a process measure gives a clear indication of the remedial action required, whereas poor performance on an outcome measure gives no such direct guidance 12 . Often, therefore it is easier to devise incentive schemes associated with process.
In practice, both processes and outcomes matter to patients. Good performance management systems should therefore include measures of both. Moreover, the division between process and outcome is rarely as stark as suggested here. There is often a spectrum between immediate process and eventual clinical outcome, covering various measures of intermediate outcome. For example, the quality of clinical management of high blood pressure could in principle be measured by process (prescribing of appropriate drugs) or outcome (long-term quality-adjusted survival). However, a good intermediate measure of success would be maintenance of blood pressure within acceptable bounds.
HOW SHOULD WE MEASURE PERFORMANCE?
The choice of measure is only the first step in performance measurement. We need to be confident that variations in measured performance accurately reflect variations in actual performance. We therefore need to disentangle the numerous potential influences on measured performance. Usually the focus is on differences in quality of service secured by clinical teams. However, there are many sources of variation that can importantly influence a performance indicator. These must be adjusted for before inferences can be drawn about the performance of the clinical team.
Clinical teams
It is not always clear what lies within the control of the team. Suppose a surgical team is grappling with a high rate of complications caused by hospital acquired infections. If these complications are taken into account, the team might seem to be doing well. But if the incidence of infection lies within the team's control, performance should be assessed on the basis of patient characteristics on admission.
Care is often delivered by more than one team. Even within one hospital, surgical outcomes might be the result of collaboration between surgical, medical and rehabilitation teams. Factors outside the institution, such as the referral practices of general practitioners, will also influence the outcome of care received in the hospital setting, making the performance of teams even harder to compare.
Patients
A fundamental requirement for comparison of performance is that differences in the type of patients treated must be allowed for; but this rudimentary insight has been widely ignored. An example is the use, as a clinical indicator, of non-emergency deaths in hospital within 30 days of surgery 13 . To account for differences in diagnoses, severity and complications, risk adjustment procedures have been developed in many specialties. In intensive care the APACHE system is commonly chosen 14 . Many risk adjustment systems are at an early stage of development, and competing mechanisms sometimes yield different results 15 . The challenge is to encourage those specialties currently with access only to rudimentary risk adjustment mechanisms to develop more sensitive and meaningful instruments. 
The institution
The institution in which a team is operating can have an important influence on outcome. This is particularly true in a hospital setting, where a team may have to accept certain arrangements as immutable. One direct influence is the level and nature of resources made available to the team. Other factors include the extent and seniority of support staff, the availability of theatre resources and the physical layout of facilities.
The external environment
Clinical outcomes are influenced by numerous local factors outside the immediate institutional setting. These include geography and transport infrastructure (affecting physical access to healthcare), arrangements for social care, employment patterns and the social fabric. Most of these are beyond the control of the clinical team, so, in principle, these should be accommodated in any interpretation of measured performance.
Random fluctuation
In addition to the systematic influences on performance, there are always random variations which persist even after adjustment for each of the influences on outcome mentioned above. By definition, these random fluctuations in measured performance are beyond the understanding or control of healthcare professionals. They should nevertheless be properly taken into account when differences in measured performance are being interpreted. Best practice in the measurement of comparative performance will therefore always entail reporting of confidence intervals in some form. Numerous analytic techniques have been developed to address the 'attribution' problem. These come under the general rubric of 'risk adjustment', which embraces procedures as diverse as control charts, Bayesian techniques, multilevel modelling and countless multivariate statistical approaches [16] [17] [18] [19] . As so often in healthcare, the appropriate approach is highly contingent on the purpose of the analysis, the nature of the data and the nature of the clinical specialty. There are furthermore important choices about how best to present analytic results to clinical professionals.
Good performance measurement is clearly an essential prerequisite of high-quality healthcare. In this paper we have argued that the choice of what to measure and how to measure have to be addressed carefully if the potential of performance measurement is to be fully realized. In part 2, we discuss ways to avoid the pitfalls of measurement.
